About
About Shionogi
Who we are
Heritage
Global affiliates and locations
Shionogi BV - tax strategy
Transparency
Investor Relations
Grants and Donations
Sustainability
Innovation
Innovation
Our areas of focus
Our Partners
Drug Discovery
Antimicrobial Resistance
News
Investors
Careers
Contact
Europe
Worldwide
HOME
News
2023
09
Reinforcing Potential Across COVID-19 Populations at ESWI 2023
Release
Medical News
2023/09/22
Shionogi Presents New Ensitrelvir Clinical and Real-World Data Reinforcing Potential Across COVID-19 Populations at ESWI 2023